Latest operating income for BFAGY: $-6.8M.
Get informed when a big investor buys or sells
+ FollowAs of Sep 30, 2026
Trailing 12 months ending Sep 30, 2026
Biofrontera AG (BFAGY) currently reports a operating income of $-6.8M as of September 2026. That compares with $-18M in the prior-year period — up 61.5% year over year. Use the charts on this page to explore Biofrontera AG's operating income history and peer comparisons.
Biofrontera AG's operating income increased from $-18M to $-6.8M — a 61.5% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Biofrontera AG reported $-6.8M in operating income as of September 2026. That compares with $-18M in the prior-year period — up 61.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current operating income of $-6.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biofrontera AG, and consider following BFAGY for alerts when major investors trade the stock.
Biofrontera AG is classified in the Healthcare sector. On operating income, it currently shows $-6.8M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BFAGY with unrelated industries.